clinical trials

The World Health Organization again calls upon researchers to register clinical trial details in freely accessible databases before initiation of the study.

The marijuana-derived compound shows promise in treating rare forms of epilepsy that cause children to have seizures multiple times a day.

Two new Ebola vaccine candidates prove safe and effective against the virus in macaques, a study shows.

Assistant Professor, Department of Medicine, Columbia University. Age: 41

Even when a clinical trial fails, some patients improve. What can researchers learn from these exceptional responders?

Scientist to Watch Yvonne Saenger explains recent advances in using biomarkers to identify cancer patients who might benefit most from immunotherapy.

A panel of oncologists discusses cases of exceptional responders, or cancer patients whose tumors disappear after a brief period of chemotherapy.

Preemptive detection and intervention will be key to easing the growing burden of cancer, particularly in developing countries.

A novel Ebola vaccine being tested in China is safe and provokes a notable immune response in people, according to a Phase 1 trial.

Despite documented dysfunction in a number of studies, rarely do those problems get a mention in the resulting publications, according to a new study.

As the number of Ebola cases declines, Chimerix is unable to recruit enough patients for its trial in Liberia testing the antiviral drug brincidofovir.

The controversial antiviral drug earns better marks in the most recent analysis of the evidence. 

Vaccine trial to start in Liberia as early as next week; trial for experimental therapy also planned, but production is still limited

The Institute of Medicine says results from human clinical trials ought to be made available to independent researchers within 18 months.

The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research

Plasma-based therapy trials begin in West Africa; NIH-GSK vaccine shows promise in Phase 1; the real statistics

NIH admits new patient; joint pains stall clinical trial; U.S. grants immunity to vaccine developers; more

A draft policy from the US National Institutes of Health suggests that clinical studies performed at multiple sites should be reviewed by a single institutional review board.